Table 1

Characteristics of chronic infected hepatitis E virus (HEV) patients

Patient	Age	Sex	SOT	Steroid*	Proliferation inhibitors*	Calcineurin inhibitors*	mTOR inhibitors*	Treatment for HEV infection*	ALT (U/L)	AST (U/L)	Bilirubin (µmol/L)	HEV genotype
Patient #1	61	m	Heart, liver	Prednisolone		Tacrolimus	Everolimus	Ribavirin	283	296	13	3c
Patient #2	39	f	Liver, kidney stem cells, lung	Prednisolone	Mycophenolate mofetil	Tacrolimus	Everolimus, sirolimus	Ribavirin	247	121	8	3c
Patient #3	52	f	Heart, lung	Prednisolone	Mycophenolic acid	Tacrolimus, ciclosporine		Ribavirin	42	42	17	3e
Patient #4	18	f	Kidney			Tacrolimus	Everolimus	Ribavirin	294	138	6	3c
Patient #5	45	f	Kidney	Prednisone	Mycophenolic acid		Everolimus	Ribavirin	374	139	9	3c
Patient #6	60	m	Heart	Prednisone	Azathioprine	Ciclosporine		Ribavirin	108	68	15	3c
Patient #7	70	m	Heart	Prednisone	Azathioprine	Ciclosporine	Everolimus<	Ribavirin	165	91	10	3c
Patient #8	14	m	Liver	Prednisolone	Mycophenolate mofetil	Tacrolimus		Ribavirin	354	168	41	3f
Patient #9	35	m	Multilocular fibrosis	Prednisone			Sirolimus	Ribavirin	473	296	n.d.	3c
Patient #10	47	m	Liver	Prednisolone		Ciclosporine		Reduction of immunosuppression	78	78	45	3c
Patient #11	65	m	Liver	Prednisolone	Mycophenolate mofetil	Tacrolimus		Reduction of immunosuppression	43	30	14	3f
Patient #12	47	m	Kidney	Prednisolone	Mycophenolate mofetil	Tacrolimus		Reduction of immunosuppression	359	171	16	3f